Pharmadil
ActiveSummary
The computed 12-month bankruptcy probability of Pharmadil is 1.6% (moderate). For Pharmadil, one filing cycle of the annual accounts is missing. The 2024 annual accounts show negative equity (-€88,047) and a net result of -€69,128. Equity is shrinking by ~62% per year across the filed fiscal years. Its solvency ranks better than 8% of 9630 sector peers (fiscal year 2024). The company has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
No current score
Figures too old
The available figures for FY 2024 are too old to assess current financial health.
Filing: One filing cycle is missing
Axes, FY 2024 · tick = 2023
Profitability16▼-22
Solvency11▼-11
Growth32=
Track record100
Bankruptcy probability, 12 months
1.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
-14.2%
Return on assets
-11.1%
Age of the figures
30 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts not filed
The financial year that closed on 31-03-2025 was due at the National Bank by 31-10-2025. Nothing is on record, 335 days later.
NBB · 10 filingsPosition against the passed deadline
31-03-2025 close31-10-2025 deadline01-10-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-03-2024 was due by 31-10-2024 and was filed on 13-11-2024, 13 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not filed
2024
13 d late
2023
1 d early
2022
10 d late
2021
16 d late
2020
26 d late
2019
21 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 7 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, abbreviated schema
Equity
-€88,047▼ 365%
2023 · -€18,919
Total assets
€620,651▼ 15.0%
2023 · €730,231
Net result
-€69,128▼ 60.0%
2023 · -€43,197
Working capital
€78,412▼ 39.4%
2023 · €129,361
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€20,596▼ 34.7%-€13,883€17,868-€33,371-€58,175▼ 74.3%
Net result€4,302below the sector's middle half▼ 54.7%-€28,482below the sector's middle half€4,116within the sector's middle half-€43,197below the sector's middle half-€69,128below the sector's middle half▼ 60.0%
Equity€48,643below the sector's middle half▲ 0.6%€20,162below the sector's middle half▼ 58.6%€24,278below the sector's middle half▲ 20.4%-€18,919below the sector's middle half-€88,047below the sector's middle half▼ 365%
Total assets€863,300within the sector's middle half▼ 3.9%€816,981within the sector's middle half▼ 5.4%€800,636within the sector's middle half▼ 2.0%€730,231within the sector's middle half▼ 8.8%€620,651within the sector's middle half▼ 15.0%
Debt€814,657▼ 4.1%€796,819▼ 2.2%€776,358▼ 2.6%€749,150▼ 3.5%€708,698▼ 5.4%
Working capital€250,321within the sector's middle half▼ 7.6%€202,841within the sector's middle half▼ 19.0%€191,571within the sector's middle half▼ 5.6%€129,361within the sector's middle half▼ 32.5%€78,412within the sector's middle half▼ 39.4%
Solvency5.6%below the sector's middle half▲ 0.3pp2.5%below the sector's middle half▼ 3.2pp3.0%below the sector's middle half▲ 0.6pp-2.6%below the sector's middle half▼ 5.6pp-14.2%below the sector's middle half▼ 11.6pp
Current ratio1.86within the sector's middle half▼ 0.301.55within the sector's middle half▼ 0.311.43within the sector's middle half▼ 0.121.25within the sector's middle half▼ 0.181.15within the sector's middle half▼ 0.10
Return on assets (ROA)0.5%below the sector's middle half▼ 0.6pp-3.5%below the sector's middle half▼ 4.0pp0.5%below the sector's middle half▲ 4.0pp-5.9%below the sector's middle half▼ 6.4pp-11.1%below the sector's middle half▼ 5.2pp
Staff (FTE)1.8within the sector's middle half▲ 5.9%1.6below the sector's middle half▼ 11.1%2within the sector's middle half▲ 25.0%2within the sector's middle half=2within the sector's middle half=
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €58,175 in 2024 against €33,371 in 2023; the loss grows and 2024 has the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €620,651
Fixed assets
€1,892 ▼ 97.6%
Current assets
€618,759 ▼ 4.9%
Equity and liabilities
Equity-€88,047
Debt€708,698
Equity is negative: debt (€708,698) exceeds the balance-sheet total (€620,651).
Key figures and ratios
EBITDA
€22,167▼
2023 · €48,017
Cash flow
€11,214▼
2023 · €38,191
Quick ratio
0.75▼
2023 · 0.80
Interest coverage
1.40▼
2023 · 3.17
Debt ≤ 1 year
€540,347▲
2023 · €521,022
Debt > 1 year
€165,146▼
2023 · €224,988
Staff costs
€137,078▲
2023 · €132,811
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | €110,355 | €132,811 | €137,078 | ▲ 3.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €81,544 | €82,570 | €82,821 | €81,388 | €80,342 | ▼ 1.3% |
| Other operating charges640/8 | - | - | €917 | €868 | €384 | ▼ 55.7% |
| Gross operating margin9900 | €217,035 | €169,457 | €211,961 | €181,696 | €159,629 | ▼ 12.1% |
| Operating profit (loss)9901 | €20,596 | -€13,883 | €17,868 | -€33,371 | -€58,175 | ▼ 74.3% |
| Financial income75/76B | - | - | €3,020 | €5,326 | €4,873 | ▼ 8.5% |
| Recurring financial income75 | €3,414 | €2,923 | €3,020 | €3,326 | €2,877 | ▼ 13.5% |
| Non-recurring financial income76B | - | - | - | €2,000 | €1,997 | ▼ 0.2% |
| Financial charges65/66B | - | - | €16,772 | €15,152 | €15,826 | ▲ 4.5% |
| Recurring financial charges65 | €18,449 | €17,522 | €16,772 | €15,152 | €15,826 | ▲ 4.5% |
| Profit (loss) for the period before taxes9903 | €5,561 | -€28,482 | €4,116 | -€43,197 | -€69,128 | ▼ 60.0% |
| Income taxes67/77 | €1,259 | - | - | - | - | - |
| Profit (loss) for the period9904 | €4,302 | -€28,482 | €4,116 | -€43,197 | -€69,128 | ▼ 60.0% |
| Profit (loss) for the period to be appropriated9905 | €4,302 | -€28,482 | €4,116 | -€43,197 | -€69,128 | ▼ 60.0% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €863,300 | €816,981 | €800,636 | €730,231 | €620,651 | ▼ 15.0% |
| Fixed assets21/28 | €320,892 | €244,058 | €161,237 | €79,849 | €1,892 | ▼ 97.6% |
| Intangible fixed assets21 | €312,000 | €234,000 | €156,000 | €78,000 | - | - |
| Tangible fixed assets22/27 | €8,892 | €10,058 | €5,237 | €1,849 | €1,892 | ▲ 2.4% |
| Plant, machinery and equipment23 | - | - | €3,041 | €885 | €1,892 | ▲ 114% |
| Other tangible fixed assets26 | - | - | €2,195 | €963 | - | - |
| Current assets29/58 | €542,408 | €572,923 | €639,399 | €650,383 | €618,759 | ▼ 4.9% |
| Stocks and contracts in progress3 | €246,957 | €258,318 | €237,638 | €232,738 | €215,783 | ▼ 7.3% |
| Stocks30/36 | - | - | €237,638 | €232,738 | €215,783 | ▼ 7.3% |
| Amounts receivable within one year40/41 | €248,874 | €291,181 | €371,122 | €392,842 | €335,248 | ▼ 14.7% |
| Trade receivables40 | - | - | €103,237 | €115,322 | €96,206 | ▼ 16.6% |
| Other amounts receivable41 | - | - | €267,886 | €277,520 | €239,042 | ▼ 13.9% |
| Cash at bank and in hand54/58 | €43,849 | €20,782 | €24,190 | €20,484 | €63,617 | ▲ 211% |
| Deferred charges and accrued income490/1 | - | - | €6,450 | €4,318 | €4,110 | ▼ 4.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €863,300 | €816,981 | €800,636 | €730,231 | €620,651 | ▼ 15.0% |
| Equity10/15 | €48,643 | €20,162 | €24,278 | -€18,919 | -€88,047 | ▼ 365% |
| Contributions10/11 | - | - | €25,000 | €25,000 | €25,000 | = |
| Reserves13 | €23,643 | €2,500 | €2,500 | €2,500 | €2,500 | = |
| Non-distributable reserves130/1 | - | - | €2,500 | €2,500 | - | - |
| Reserves not available under the articles1311 | - | - | €2,500 | €2,500 | - | - |
| Distributable reserves133 | - | - | - | - | €2,500 | - |
| Profit (loss) carried forward14 | - | -€7,338 | -€3,222 | -€46,419 | -€115,547 | ▼ 149% |
| Amounts payable17/49 | €814,657 | €796,819 | €776,358 | €749,150 | €708,698 | ▼ 5.4% |
| Amounts payable after more than one year17 | €520,047 | €424,089 | €325,756 | €224,988 | €165,146 | ▼ 26.6% |
| Financial debts170/4 | - | - | €325,756 | €224,988 | €165,146 | ▼ 26.6% |
| Amounts payable within one year42/48 | €292,087 | €370,082 | €447,829 | €521,022 | €540,347 | ▲ 3.7% |
| Current portion of amounts payable after more than one year42 | - | - | €98,333 | €100,768 | €59,842 | ▼ 40.6% |
| Financial debts43 | - | - | €120,000 | €125,000 | €125,000 | = |
| Credit institutions430/8 | - | - | €120,000 | €125,000 | €125,000 | = |
| Trade debts44 | €122,539 | €134,561 | €96,973 | €85,654 | €112,444 | ▲ 31.3% |
| Suppliers440/4 | - | - | €96,973 | €85,654 | €112,444 | ▲ 31.3% |
| Taxes, remuneration and social security45 | - | - | €13,892 | €16,060 | €22,521 | ▲ 40.2% |
| Taxes450/3 | - | - | - | - | €54 | - |
| Remuneration and social security454/9 | - | - | €13,892 | €16,060 | €22,467 | ▲ 39.9% |
| Other amounts payable47/48 | - | - | €118,631 | €193,540 | €220,540 | ▲ 14.0% |
| Accrued charges and deferred income492/3 | - | - | €2,773 | €3,140 | €3,205 | ▲ 2.1% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €4,302 | -€28,482 | €4,116 | -€43,197 | -€69,128 | ▼ 60.0% |
| + Depreciation and write-downs630 | €81,544 | €82,570 | €82,821 | €81,388 | €80,342 | ▼ 1.3% |
| Operating cash flow (approximation) | €85,846 | €54,089 | €86,937 | €38,191 | €11,214 | ▼ 70.6% |
| Investment in fixed assets (approximation) | - | -€5,737 | €0 | €0 | -€2,385 | - |
| Change in cash | - | -€23,067 | €3,408 | -€3,706 | €43,133 | ▲ 1,264% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2024
13-11
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 13 days late
31-03
Financial
Weakest financial yearnet -€69,128
Net result drops to -€69,128, the lowest in the series.
2023
30-10
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2022
10-11
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 10 days late
31-03
Financial
Back to profitnet €4,116
Net result €4,116 after one loss-making year.
2021
16-11
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 16 days late
2020
26-11
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 26 days late
2019
10-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
23-10
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
15-09
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
06-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2015
06-10
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 4 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2014
Ground area
1,110 m²
Building footprint
312 m²
Volume, LiDAR
2,434 m³
2 parcels, Flanders · tallest building 11.7 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Pharmadil
since 20142.229.641.010
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23016D0215/00E006 | Flanders | 634 m² | 1 · 194 m² | 11.7 m · 3 fl. |
| 23352F0220/00R005 | Flanders | 476 m² | 1 · 118 m² | 10.1 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 ownerChain of control
- MSP INVEST
- Pharmadil
Highest known parent: MSP INVEST. The sources do not say who stands above it.
Owners 1
- MSP INVESTparent99.9%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Subsidies and aid
Flemish government
2022 to 2025 · 2 entries · 4,000 EUR awarded · 4,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 2,000 EUR | 2,000 EUR |
| 2022 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Similar companies · same sector, comparable size
APOTHEEK DERUMEAUX
BE 0405.328.059
Harelbeke · FTE 2
PHARMACIE DES CLOITRES
BE 0405.621.039
Amay · FTE 2
Apotheek P. Hostens
BE 0406.780.386
Antwerpen · FTE 2
Pharmacie du progrès
BE 0406.979.831
Charleroi · FTE 2
Apotheek Clessens
BE 0408.406.028
Antwerpen · FTE 2
Of 5,219 companies in this sector we hold annual accounts for 3,862. 2,295 are within a factor 10 of this headcount. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded28-03-2014
Fiscal year end31-03
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0549774521
Also
9925:BE0549774521
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.